US Stock MarketDetailed Quotes

ArriVent BioPharma (AVBP)

Watchlist
  • 30.420
  • -0.580-1.87%
Close Apr 24 16:00 ET
  • 30.000
  • -0.420-1.38%
Post 19:55 ET
1.34BMarket Cap-7.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ArriVent BioPharma (AVBP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-128.72%-160.59M
-89.81%-30.66M
-119.01%-35.8M
-36.87%-26.12M
-265.08%-68.01M
-25.73%-70.21M
-8.31%-16.15M
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
Net income from continuing operations
-106.62%-166.31M
-72.27%-35.54M
-70.09%-34.98M
-43.54%-31.4M
-269.68%-64.39M
-16.09%-80.49M
2.64%-20.63M
-42.80%-20.56M
-1.42%-21.87M
-43.09%-17.42M
Other non cash items
---3.03M
----
----
----
----
----
----
----
----
----
Change In working capital
-153.40%-3.77M
32.90%4.69M
-235.28%-4.54M
-2.87%1.96M
-220.92%-5.89M
-43.89%7.07M
-40.80%3.53M
366.53%3.35M
-84.16%2.02M
62.34%-1.84M
-Change in prepaid assets
-957.99%-12.56M
-80.74%275K
-2,277.85%-6.49M
-2,032.93%-4.76M
-213.19%-1.59M
-84.86%1.46M
-64.66%1.43M
-86.35%298K
-95.83%246K
79.30%-508K
-Change in payables and accrued expense
56.56%8.81M
109.88%4.42M
-35.93%1.96M
274.03%6.73M
-221.39%-4.3M
91.69%5.63M
9.12%2.11M
188.64%3.06M
-73.84%1.8M
44.71%-1.34M
-Change in other current assets
--0
--0
--0
--0
--0
42.86%-20K
97.14%-1K
--0
-157.14%-18K
66.67%-1K
-Change in other current liabilities
-950.00%-21K
-25.00%-5K
-50.00%-6K
-50.00%-6K
-140.00%-4K
-108.00%-2K
-116.00%-4K
---4K
---4K
--10K
Cash from discontinued investing activities
Operating cash flow
-128.72%-160.59M
-89.81%-30.66M
-119.01%-35.8M
-36.87%-26.12M
-265.08%-68.01M
-25.73%-70.21M
-8.31%-16.15M
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
Investing cash flow
Cash flow from continuing investing activities
62.99%-71.23M
63.01%-71.2M
-50.76M
13.91M
36.82M
-192.47M
-869.86%-192.47M
0
0
0
Net investment purchase and sale
62.99%-71.23M
63.01%-71.2M
---50.76M
--13.91M
--36.82M
---192.47M
-869.86%-192.47M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
62.99%-71.23M
63.01%-71.2M
---50.76M
--13.91M
--36.82M
---192.47M
-869.86%-192.47M
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
8.83%203.06M
63,036.36%34.73M
16,183.43%86.47M
20,592.56%75.11M
-96.36%6.76M
335.34%186.58M
105.20%55K
151.40%531K
1,915.00%363K
312.80%185.63M
Net common stock issuance
8.97%202.63M
--34.66M
--86.12M
23,517.87%75.34M
-96.49%6.52M
--185.95M
--0
--0
--319K
--185.63M
Net preferred stock issuance
----
----
----
----
----
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-20.44%502K
52.73%84K
-90.77%49K
72.73%76K
29,200.00%293K
78.25%631K
-80.70%55K
1,261.54%531K
1,000.00%44K
-96.15%1K
Net other financing activities
---70K
---17K
--300K
---303K
---50K
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
8.83%203.06M
63,036.36%34.73M
16,183.43%86.47M
20,592.56%75.11M
-96.36%6.76M
335.34%186.58M
105.20%55K
151.40%531K
1,915.00%363K
312.80%185.63M
Net cash flow
Beginning cash position
-50.60%74.29M
-60.17%112.67M
-62.24%112.77M
-84.29%49.87M
-50.60%74.29M
-7.95%150.39M
100.10%282.86M
89.23%298.67M
65.78%317.39M
-7.95%150.39M
Current changes in cash
62.21%-28.75M
67.81%-67.13M
99.41%-93K
435.93%62.9M
-114.63%-24.43M
-486.12%-76.1M
-2,409.66%-208.56M
4.01%-15.81M
44.32%-18.72M
494.57%167M
End cash Position
-38.70%45.54M
-38.70%45.54M
-60.17%112.67M
-62.24%112.77M
-84.29%49.87M
-50.60%74.29M
-50.60%74.29M
100.10%282.86M
89.23%298.67M
65.78%317.39M
Free cash flow
-128.72%-160.59M
-89.81%-30.66M
-119.01%-35.8M
-36.87%-26.12M
-265.08%-68.01M
-25.73%-70.21M
-8.31%-16.15M
-5.85%-16.35M
-121.79%-19.09M
-10.35%-18.63M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -128.72%-160.59M-89.81%-30.66M-119.01%-35.8M-36.87%-26.12M-265.08%-68.01M-25.73%-70.21M-8.31%-16.15M-5.85%-16.35M-121.79%-19.09M-10.35%-18.63M
Net income from continuing operations -106.62%-166.31M-72.27%-35.54M-70.09%-34.98M-43.54%-31.4M-269.68%-64.39M-16.09%-80.49M2.64%-20.63M-42.80%-20.56M-1.42%-21.87M-43.09%-17.42M
Other non cash items ---3.03M------------------------------------
Change In working capital -153.40%-3.77M32.90%4.69M-235.28%-4.54M-2.87%1.96M-220.92%-5.89M-43.89%7.07M-40.80%3.53M366.53%3.35M-84.16%2.02M62.34%-1.84M
-Change in prepaid assets -957.99%-12.56M-80.74%275K-2,277.85%-6.49M-2,032.93%-4.76M-213.19%-1.59M-84.86%1.46M-64.66%1.43M-86.35%298K-95.83%246K79.30%-508K
-Change in payables and accrued expense 56.56%8.81M109.88%4.42M-35.93%1.96M274.03%6.73M-221.39%-4.3M91.69%5.63M9.12%2.11M188.64%3.06M-73.84%1.8M44.71%-1.34M
-Change in other current assets --0--0--0--0--042.86%-20K97.14%-1K--0-157.14%-18K66.67%-1K
-Change in other current liabilities -950.00%-21K-25.00%-5K-50.00%-6K-50.00%-6K-140.00%-4K-108.00%-2K-116.00%-4K---4K---4K--10K
Cash from discontinued investing activities
Operating cash flow -128.72%-160.59M-89.81%-30.66M-119.01%-35.8M-36.87%-26.12M-265.08%-68.01M-25.73%-70.21M-8.31%-16.15M-5.85%-16.35M-121.79%-19.09M-10.35%-18.63M
Investing cash flow
Cash flow from continuing investing activities 62.99%-71.23M63.01%-71.2M-50.76M13.91M36.82M-192.47M-869.86%-192.47M000
Net investment purchase and sale 62.99%-71.23M63.01%-71.2M---50.76M--13.91M--36.82M---192.47M-869.86%-192.47M--0--0--0
Cash from discontinued investing activities
Investing cash flow 62.99%-71.23M63.01%-71.2M---50.76M--13.91M--36.82M---192.47M-869.86%-192.47M--0--0--0
Financing cash flow
Cash flow from continuing financing activities 8.83%203.06M63,036.36%34.73M16,183.43%86.47M20,592.56%75.11M-96.36%6.76M335.34%186.58M105.20%55K151.40%531K1,915.00%363K312.80%185.63M
Net common stock issuance 8.97%202.63M--34.66M--86.12M23,517.87%75.34M-96.49%6.52M--185.95M--0--0--319K--185.63M
Net preferred stock issuance ----------------------0--0--0--0--0
Proceeds from stock option exercised by employees -20.44%502K52.73%84K-90.77%49K72.73%76K29,200.00%293K78.25%631K-80.70%55K1,261.54%531K1,000.00%44K-96.15%1K
Net other financing activities ---70K---17K--300K---303K---50K--------------------
Cash from discontinued financing activities
Financing cash flow 8.83%203.06M63,036.36%34.73M16,183.43%86.47M20,592.56%75.11M-96.36%6.76M335.34%186.58M105.20%55K151.40%531K1,915.00%363K312.80%185.63M
Net cash flow
Beginning cash position -50.60%74.29M-60.17%112.67M-62.24%112.77M-84.29%49.87M-50.60%74.29M-7.95%150.39M100.10%282.86M89.23%298.67M65.78%317.39M-7.95%150.39M
Current changes in cash 62.21%-28.75M67.81%-67.13M99.41%-93K435.93%62.9M-114.63%-24.43M-486.12%-76.1M-2,409.66%-208.56M4.01%-15.81M44.32%-18.72M494.57%167M
End cash Position -38.70%45.54M-38.70%45.54M-60.17%112.67M-62.24%112.77M-84.29%49.87M-50.60%74.29M-50.60%74.29M100.10%282.86M89.23%298.67M65.78%317.39M
Free cash flow -128.72%-160.59M-89.81%-30.66M-119.01%-35.8M-36.87%-26.12M-265.08%-68.01M-25.73%-70.21M-8.31%-16.15M-5.85%-16.35M-121.79%-19.09M-10.35%-18.63M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -